Harpoon Therapeutics Ownership
| HARPDelisted Stock | USD 0.85 0.00 0.00% |
Harpoon |
Harpoon Stock Ownership Analysis
About 83.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 8.62. Harpoon Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 5th of September 2023. Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. To learn more about Harpoon Therapeutics call Julie MBA at 650 443 7400 or check out https://www.harpoontx.com.Harpoon Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harpoon Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harpoon Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Harpoon Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jonathan Drachman over six months ago Acquisition by Jonathan Drachman of 415 shares of Harpoon Therapeutics subject to Rule 16b-3 | ||
Walker Luke Nathaniel over a year ago Acquisition by Walker Luke Nathaniel of 115000 shares of Harpoon Therapeutics subject to Rule 16b-3 | ||
Silvernail Lauren P over a year ago Acquisition by Silvernail Lauren P of 5000 shares of Harpoon Therapeutics subject to Rule 16b-3 | ||
Silvernail Lauren P over a year ago Acquisition by Silvernail Lauren P of 23000 shares of Harpoon Therapeutics subject to Rule 16b-3 | ||
Viney Joanne L over a year ago Acquisition by Viney Joanne L of 21028 shares of Harpoon Therapeutics subject to Rule 16b-3 |
Harpoon Therapeutics Outstanding Bonds
Harpoon Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Harpoon Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Harpoon bonds can be classified according to their maturity, which is the date when Harpoon Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Pair Trading with Harpoon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harpoon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harpoon Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Harpoon Stock
| 0.65 | EC | Ecopetrol SA ADR Buyout Trend | PairCorr |
Moving against Harpoon Stock
| 0.52 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.51 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.49 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.49 | JNJ | Johnson Johnson | PairCorr |
| 0.47 | KO | Coca Cola Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Harpoon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Harpoon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Harpoon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Harpoon Therapeutics to buy it.
The correlation of Harpoon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Harpoon Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Harpoon Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Harpoon Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance |